Guided Therapeutics (GTHP) FCF Payout Ratio (2023 - 2024)
Guided Therapeutics (GTHP) posted FCF Payout Ratio of 0.26 for Q2 2024, up 60.77% sequentially from 0.65 in Q1 2024.
Guided Therapeutics (GTHP) FCF Payout Ratio (2023 - 2024) Analysis & Trends
Guided Therapeutics has reported FCF Payout Ratio for 2 years, with the latest figure at 0.26 in Q2 2024.
- Quarterly FCF Payout Ratio changed N/A year-over-year to 0.26 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was 0.11 (down 209.28% YoY) and the FY2023 annual result came in at 0.04, up 52.99% from the prior year.
- FCF Payout Ratio advanced to 0.26 in Q2 2024 per GTHP's latest filing, from 0.65 in the prior quarter.
- Over five years, FCF Payout Ratio peaked at 0.13 in Q1 2023 and troughed at 0.65 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 0.55 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 0.32 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 0.44 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 0.24 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -0.73 |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 0.22 |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -0.26 |
| Mar 31, 2024 | -0.65 |
| Mar 31, 2023 | -0.13 |